BioSpace News Archive

Genetown

Verastem Oncology Presents Further COPIKTRA™ (Duvelisib) Data at the 23rd Annual International Congress on Hematologic Malignancies

DUO™ Crossover Extension Study Demonstrates 77% ORR and Median PFS of 15 Months in Patients with Relapsed or Refractory CLL/SLL Who Had Experienced Disease Progression Following Ofatumumab Monotherapy; Achieves 80% ORR in Patients with 17p Deletion

March 7, 2019
·
28 min read
Deals

ResMed Acquires HB Healthcare to Help Millions of Koreans Living with Sleep Apnea, Other Respiratory Conditions

ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, announced that is has completed the acquisition of HB Healthcare to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.

March 7, 2019
·
3 min read
BioCapital

GlycoMimetics to Present at the Cowen and Company 39th Annual Health Care Conference 2019

GlycoMimetics, Inc. announced that Chief Executive Officer Rachel King will provide a company overview at the Cowen and Company 39th Annual Health Care Conference in Boston, on Tuesday, March 12, 2019, at 9:20 a.m. ET.

March 7, 2019
·
1 min read
Policy

Co-Diagnostics, Inc. Receives CE Mark for Zika/Dengue/Chikungunya Multiplex Test

Logix Smart™ ZDC Test now available for export from the United States as a CE-marked IVD

March 7, 2019
·
4 min read
Biotech Beach

Beckman Coulter’s HbA1c Advanced Assay Provides Physicians with Greater Accuracy when Diagnosing Patients with Diabetes

New assay achieves CE Mark Certification and U.S. FDA 501(k) Clearance

March 7, 2019
·
3 min read
Policy

MCRA Assists with Premarket Approval of the M6-C Artificial Cervical Disc

- 1st Spine PMA Approved by the FDA in More than Three Years

March 7, 2019
·
2 min read
Deals

Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer

Eli Lilly and Company (NYSE: LLY) today announced the final exchange ratio for its previously-announced offer for shareholders to exchange their shares of Lilly common stock for shares of Elanco Animal Health Incorporated (NYSE: ELAN) owned by Lilly.

March 7, 2019
·
5 min read
Business

Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors

Proteostasis Therapeutics, Inc. today announced that David Arkowitz has been appointed to the Company’s Board of Directors. Mr. Arkowitz is the Chief Financial Officer (CFO) and Treasurer of Flexion Therapeutics, a publicly traded, commercial stage biotechnology company.

March 7, 2019
·
4 min read
Deals

SOM Biotech Closes a Financing Round of 7M Euros

SOM Biotech has just closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector which will give the opportunity to get a facilitated access to pharma network.

March 7, 2019
·
3 min read
FDA

FDA Grants Breakthrough Designation to Paige.AI

Expedites Product Development and Provides Priority Regulatory Review For Paige.AI’s Pioneering Clinical-Grade Artificial Intelligence in Pathology

March 7, 2019
·
2 min read